UPDATE: Bank Of America Downgrades Pfizer To Neutral, Lowers Target From $49 To $41  Based On Firm's 'updated SOTP valuation, including expected dilution from Upjohn spin-merge (Reverse Morris Trust) and valuation outlook for RemainCo'